Hormones & Peptides·January 9, 2026

Ipamorelin vs. Sermorelin: Which Growth Hormone Peptide Is Right for You?

Both ipamorelin and sermorelin stimulate growth hormone release — but they work differently and suit different clinical goals. Here's how to think about the choice.

The Growth Hormone Decline Problem

Growth hormone (GH) peaks in your mid-20s and declines roughly 14% per decade after that. By 40, most adults have significantly less GH than they did at their metabolic prime.

The consequences are real: reduced muscle mass, increased body fat (particularly visceral), impaired sleep quality, slower recovery, and diminished cognitive sharpness.

Growth hormone peptides — also called GH secretagogues — work by stimulating your pituitary to produce and release more of your own growth hormone. They don't replace GH; they optimize your body's native production.

Two of the most commonly prescribed are ipamorelin and sermorelin. Here's how they differ.

Sermorelin: The Classic

Sermorelin is a synthetic analog of GHRH (Growth Hormone Releasing Hormone) — the signal your hypothalamus sends to your pituitary to trigger GH release.

How it works: Mimics the natural GHRH pulse, stimulating a physiologic release of growth hormone.

Clinical profile:

  • Well-established safety record (used in pediatric GH deficiency for decades)
  • Produces a natural, pulsatile GH release pattern
  • Half-life is short — typically administered at night to align with the body's natural GH pulse during sleep
  • Results tend to be gradual but sustainable

Best for: Patients looking for a conservative, well-studied entry point into GH optimization; anti-aging protocols; general sleep and body composition improvement.

Ipamorelin: The Precision Tool

Ipamorelin is a GHRP (Growth Hormone Releasing Peptide) — it works on a different receptor (ghrelin receptor) and has a distinct mechanism from sermorelin.

How it works: Stimulates GH release via the ghrelin pathway, often combined with a GHRH analog like CJC-1295 for synergistic effect.

Clinical profile:

  • Highly selective — stimulates GH without significantly increasing cortisol, prolactin, or appetite (unlike earlier GHRPs)
  • Clean side effect profile
  • When combined with CJC-1295 (a long-acting GHRH analog), produces a sustained elevation in GH and IGF-1
  • Typically administered 2–3x daily or at night

Best for: Patients with specific performance or body composition goals; those who want stronger, faster results; post-injury recovery protocols.

The Combination Approach: CJC-1295 + Ipamorelin

This is currently the most popular GH peptide protocol. By combining a GHRH analog (CJC-1295) with a GHRP (ipamorelin), you stimulate both arms of the GH secretion pathway simultaneously — producing synergistic increases in GH and IGF-1.

Expected benefits with consistent use (typically 3–6 months):

  • Improved body composition (reduced fat, increased lean mass)
  • Enhanced sleep quality and recovery
  • Increased energy and mental clarity
  • Improved skin elasticity and connective tissue health

How We Decide

The right peptide depends on your labs (baseline IGF-1 is essential), your goals, your current health status, and what other interventions you're on. This is not a self-prescribing territory.

We build individualized protocols — not cookie-cutter stacks.


PracticeRx prescribes growth hormone peptide protocols through our licensed providers, sourced from accredited compounding pharmacies.

Ready to take the next step?

Get clarity on what's actually going on with your biology.

Request a Consultation